Phillips Andrew John 4
4 · OnKure Therapeutics, Inc. · Filed May 30, 2025
Insider Transaction Report
Form 4
Phillips Andrew John
Director
Transactions
- Award
Stock Option (right to buy)
2025-05-28+7,650→ 7,650 totalExercise: $2.44Exp: 2035-05-27→ Class A Common Stock (7,650 underlying)
Footnotes (1)
- [F1]100% of the shares subject to the option will vest on the earlier of May 28, 2026 or the day prior to the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through the applicable vesting date.